The Conversation (0)
GT Biopharma announced a 1-for-300 reverse stock split.
GT Biopharma (OTCQB:OXIS) announced a 1-for-300 reverse stock split.
As quoted in the press release:
Shareholders of GT Biopharma Inc. (OTCQB: OXIS and Euronext Paris: OXI.PA) will be issued 1 share of common stock for every 300 shares common stock that they owned.
After the completed reverse split, there will be approximately 500,000 shares of GT Biopharma stock issued and outstanding. The reverse split was a requirement of the acquisition of Georgetown Translational Pharmaceuticals by GT Biopharma Inc. The new company’s stock will trade under the symbol GTBP.
Click here to read the full press release.
Source: www.accesswire.com
